Amphetamine‐type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin

By R. Rothman, M. Baumann, C. Dersch, Dana V. Romero, K. Rice, F. Carroll, J. Partilla. Synapse, 2001

950 citations recorded by the source corpus.

Subfields: Cellular and Molecular Neuroscience, Clinical Psychology, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/6a277c37225f36d92c7d7a7fcc27bbf3cf7f62de

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cellular and Molecular Neuroscience

1. David J. Nutt

In Clinical Psychology

1. David J. Nutt
2. Robin L. Carhart-Harris

In Molecular Biology

1. David J. Nutt

Citations in the corpus

• Pharmacological characterization of designer cathinones in vitro (2013, background): “The potency of drugs of abuse to inhibit the NET and DAT or activate the NA and DA system is associated with their psychostimulant effects and enhanced abuse liability (Rothman et al., 2001).”
• The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”) (2003, background): “In a synaptosomal preparation, MDMA induced NE release with similar potency to 5-HT and greater than that for DA (Rothman et al., 2001).”
• Amphetamine, past and present – a pharmacological and clinical perspective (2013, background): “…are experimental reports stating that d-amphetamine releases [ 3 H] noradrenaline, dopamine and 5-HT from synaptosomes (Holmes and Rutledge, 1976; Rothman et al., 2001) and brain slices (Heal et al., 1998). l-Amphetamine releases noradrenaline , dopamine and 5-HT from synaptosomes (Heikkila et…”